Gary Kipp v. United States

88 F.3d 681
CourtCourt of Appeals for the Eighth Circuit
DecidedJuly 12, 1996
Docket95-2453
StatusPublished
Cited by1 cases

This text of 88 F.3d 681 (Gary Kipp v. United States) is published on Counsel Stack Legal Research, covering Court of Appeals for the Eighth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Gary Kipp v. United States, 88 F.3d 681 (8th Cir. 1996).

Opinion

BEAM, Circuit Judge.

Gary Kipp (Kipp) appeals the district court’s 1 order granting judgment to the government on his negligence claims in which he sought to recover damages for the death of his mother (Cheryl Kipp) due to a blood transfusion contaminated with the human immunodeficiency virus (HIV)- Because Kipp failed to prove causation, a required element of his negligence claims, we affirm.

I. BACKGROUND

Kipp brought this negligence action under the Federal Tort Claims Act, 28 U.S.C. §§ 1346(b) & 2671, both in his individual capacity and in his capacity as the representative of Cheryl Kipp’s estate. The HIV-contaminated blood was donated on January 16, 1985, at Camp Memorial Blood Center (Blood Center) by Darryl Bonner when he was in basic training for the United States Army in Kentucky. Cheryl Kipp received the transfusion in February of 1985 while undergoing a hysterectomy at Ehrling Bergquist Hospital at Offutt Air Force Base in Nebraska. In May 1989, Cheryl Kipp died from complications associated with acquired immunodeficiency syndrome (AIDS).

Reported cases involving the transmission of AIDS through blood transfusions first appeared in 1982. In response to that newly-discovered threat, in March 1983, the Food and Drug Administration (FDA) issued a memorandum advising all establishments collecting blood for transfusion to provide: (1) educational programs informing persons in certain “high risk” groups that they should refrain from donating blood until a definitive AIDS test was developed; (2) re-education of personnel responsible for donor screening to identify signs and symptoms of AIDS in po *683 tential donors; and (3) a standard operating procedure whereby blood collected from a donor suspected of having AIDS was labeled or quarantined and destroyed.

In December 1984, the FDA issued another memorandum to all registered blood banks in the United States. In this document, the FDA stated that blood banks should: (1) provide educational materials to potential donors in order to inform them of which groups were at high risk of contracting or carrying HIV; (2) ask donors specific questions about their medical histories in order to determine whether a donor may have contracted HIV; (3) provide donors with a confidential means of preventing their blood or plasma from being used in a transfusion or in making plasma derivatives; and (4) institute special procedures for handling blood products known to be infected with HIV. These December 1984 recommendations were adopted by the Army on February 13,1985.

In January 1985, when Bonner donated his blood, there was no scientifically reliable test to determine whether blood was infected with HIV. The Blood Center staff conducted an orientation, pursuant to their standard procedure, for all potential blood donors, including Bonner. He received a pamphlet that identified groups at high risk of contracting AIDS, and requested people who thought they fell into one of these groups to refrain from donating blood. The pamphlet described specific signs and symptoms of AIDS. Additionally, a Blood Center employee read the AIDS informational material aloud to potential donors. Moreover, each donor, including Bonner, received a card which requested information regarding that person’s health. Bonner completed, and signed, the donor card on which he indicated he was in good health. Rachel Harris De-maree, a senior sergeant at the Blood Center, conducted a confidential interview and reviewed Bonner’s answers on the donor card with him. Demaree and a phlebotomist at the Blood Center then conducted a physical examination of Bonner, during which his arms were examined and his vital signs obtained. Demaree also cheeked Bonner for Kaposi’s sarcoma, a rare form of cancer sometimes associated with AIDS, but found no indications of the disease. Later, however, Bonner tested positive for HIV. In April 1989, he died from AIDS-related complications.

At trial, Kipp claimed that the Blood Center was negligent in its screening of the blood because it failed to follow FDA recommendations on proper screening procedures. After conducting a bench trial, the district court held that Kipp failed to prove his negligence claims and granted judgment to the defendants. Applying a professional standard of care analysis, the district court stated that Kipp failed to provide any expert testimony on the standard of care for blood banks in Kentucky and relied instead on a negligence claim based on FDA recommendations, which the court concluded did not establish the applicable standard of care. The district court also affirmed the magistrate judge’s order prohibiting all of Kipp’s lay witnesses from testifying due to a violation of the court’s progression order.

On appeal, Kipp first contends that the industry standards of military blood gathering are controlled by the Military Blood Program Office (MBPO) operating under the FDA recommendations. Because these recommendations were not followed in the present case, Kipp asserts the defendants’ actions constitute negligence per se. Kipp also argues that the order to exclude all of his lay witnesses violates the law of this circuit. Finally, he alleges that under Kentucky law an ordinary standard of negligence, rather than a professional standard, applies to blood banks.

The defendants assert that the applicable standard of care under Kentucky law is the professional standard. They also contend, however, that their actions satisfied any negligence standard. Moreover, according to the defendants, Kipp failed to establish any causal link between the alleged deficiencies in the screening process and Cheryl Kipp contracting AIDS. The defendants also argue that striking all lay witness did not “constitute a dismissal,” as Kipp contends, because the magistrate judge has broad discretion in fashioning remedies for a violation of a discovery order, including prohibiting *684 the admission of evidence. Lastly, the defendants raise the discretionary function exception to the Federal Tort Claims Act as a defense.

II. DISCUSSION

This tragic case requires us to determine whether Kipp proved that the defendants were negligent in screening or taking the HIV contaminated blood, thereby causing his mother to contract the fatal virus. Kipp asserts that the defendants’ failure to comply with the FDA recommendations constitutes negligence per se. Moreover, according to Kipp, failure to comply with the FDA recommendations also violated an applicable Kentucky statute, 2 thereby constituting negligence per se. Assuming, without deciding, the validity of Kipp’s position, negligence per se would only satisfy the duty and breach of duty elements of his negligence claims. See generally Restatement (Second) of Torts § 288B cmt. b (1965). Therefore, Kipp must still prove that the alleged breach — i.e., inadequate screening of the donor for HIV— caused his mother to contract AIDS. See, e.g., Peak v. Barlow Homes, Inc., 765 S.W.2d 577, 578 (Ky.Ct.App.1988).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kipp v. United States
88 F.3d 681 (Eighth Circuit, 1996)

Cite This Page — Counsel Stack

Bluebook (online)
88 F.3d 681, Counsel Stack Legal Research, https://law.counselstack.com/opinion/gary-kipp-v-united-states-ca8-1996.